NCT06825728View on ClinicalTrials.gov

Metoprolol in Patients With HFrEF and COPD

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

311

Participants

Timeline

Start Date

February 28, 2025

Primary Completion Date

February 29, 2028

Study Completion Date

February 29, 2028

Conditions
Heart Failure With Reduced Ejection Fraction (HFrEF)COPD (Chronic Obstructive Pulmonary Disease)
Interventions
DRUG

Different doses of Metoprolol.

The control group received 23.75mg/d of metoprolol, and the experimental group received the maximum tolerable dose of metoprolol.

All Listed Sponsors
lead

Xiangya Hospital of Central South University

OTHER